Contact
Privacy Policy
Term of Use
Purchase Terms
COVID-19 Statement

Company
- About
- Leadership
- Contact
Careers
- Job Openings
Investors & Media

Select Page

Management and Progression of Arginase 1 Deficiency Over 2 Decades of Follow Up

by Tom Haan | Nov 15, 2021

Search

Recent Comments

Company

About
Leadership
Contact

Careers

Job Openings

Investors & Media

Company Overview
Press Releases
Events & Presentations
Stock Information
Financials
Corporate Governance
Resources

© 2023 Aeglea BioTherapeutics. Privacy Policy Terms of Use Purchase Terms

Aeglea BioTherapeutics is now Spyre Therapeutics.

View Press Release

Continue to www.spyre.com

Welcome
About ARG1-D
Diagnosing ARG1-D
Managing ARG1-D
Patient Advocacy
Connect